Scientists have identified a new antibiotic that showed activity against several vexing bacteria in mouse studies, including methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant tuberculosis (MDR-TB).
TOKYO – In the nearly 12 years since the completion of the Human Genome Project, next-generation sequencing methods have made genome sequencing both faster and cheaper, leading to massive increases in the numbers of individuals who can be sequenced. Projects have gone from the Human Genome Project, to the 1,000 Genomes Project, to the announcement last week of a 100,000 Genomes Project that plans to start recruiting patients in February 2015. (See BioWorld Today, Dec. 23, 2014.)
TOKYO – Even considering that much of the industry deals with life and death matters by the nature of the field, stem cells have long been a high drama part of biotechnology. And 2014 was no exception to that rule.
The search for ways to increase life span is based on the idea that such an increased life span will extend the good parts of life – meaning, by and large, the healthy parts.
TOKYO – In the nearly 12 years since the completion of the Human Genome Project, next-generation sequencing methods have made genome sequencing both faster and cheaper, leading to massive increases in the numbers of individuals who can be sequenced.
TOKYO – Even considering that much of the industry deals with life and death matters by the nature of the field, stem cells have long been a high drama part of biotechnology. And 2014 was no exception to that rule.
Researchers have used a novel screening method to gain insight into the causes behind both intrinsic and acquired resistance that can foil treatment with targeted cancer therapies.
Treatment with histone deacetylase (HDAC) inhibitors can improve the symptoms of Huntington’s disease in a mouse model of the disorder – and can improve their untreated sons’ future symptoms as well, an example of a so-called transgenerational drug effect.
Scientists have developed a vaccine that partially protected deer from developing chronic wasting disease (CWD), a prion disease that is the deer equivalent of Creutzfeldt-Jakob disease and other prion diseases, as well as Scrapie in sheep, and bovine spongiform encephalopathy (BSE or 'mad cow disease') in cattle.
Broadly neutralizing antibodies to dengue virus that recognize a repeated motif on the viral envelope might pave the way for a better vaccine, scientists reported this week.
